JP2024530990A5 - - Google Patents
Info
- Publication number
- JP2024530990A5 JP2024530990A5 JP2024513439A JP2024513439A JP2024530990A5 JP 2024530990 A5 JP2024530990 A5 JP 2024530990A5 JP 2024513439 A JP2024513439 A JP 2024513439A JP 2024513439 A JP2024513439 A JP 2024513439A JP 2024530990 A5 JP2024530990 A5 JP 2024530990A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- composition according
- inflammatory
- binding protein
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163238657P | 2021-08-30 | 2021-08-30 | |
| US63/238,657 | 2021-08-30 | ||
| US202263324784P | 2022-03-29 | 2022-03-29 | |
| US63/324,784 | 2022-03-29 | ||
| PCT/US2022/075639 WO2023034778A1 (en) | 2021-08-30 | 2022-08-30 | Method of treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024530990A JP2024530990A (ja) | 2024-08-27 |
| JP2024530990A5 true JP2024530990A5 (enExample) | 2025-09-08 |
Family
ID=85411616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513439A Pending JP2024530990A (ja) | 2021-08-30 | 2022-08-30 | 治療方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250188194A1 (enExample) |
| EP (1) | EP4396225A4 (enExample) |
| JP (1) | JP2024530990A (enExample) |
| AU (1) | AU2022337199A1 (enExample) |
| CA (1) | CA3230295A1 (enExample) |
| WO (1) | WO2023034778A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025129254A1 (en) * | 2023-12-19 | 2025-06-26 | Nucleus Therapeutics Pty Ltd | Composition comprising a cell penetrating, anti-dna binding protein and methods of treatment |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2744840T3 (es) * | 2011-04-01 | 2020-02-26 | Univ Yale | Anticuerpos anti-ADN que penetran en las células y usos de los mismos para inhibir la reparación del ADN |
| WO2017218825A1 (en) * | 2016-06-15 | 2017-12-21 | Yale University | Antibody-mediated autocatalytic, targeted delivery of nanocarriers to tumors |
| US20210340279A1 (en) * | 2018-08-31 | 2021-11-04 | Yale University | Compositions and methods of using cell-penetrating antibodies in combination with immune checkpoint modulators |
| WO2021077070A1 (en) * | 2019-10-18 | 2021-04-22 | Yale University | Compositions and methods for inhibition of cell-penetrating antibodies |
-
2022
- 2022-08-30 JP JP2024513439A patent/JP2024530990A/ja active Pending
- 2022-08-30 CA CA3230295A patent/CA3230295A1/en active Pending
- 2022-08-30 WO PCT/US2022/075639 patent/WO2023034778A1/en not_active Ceased
- 2022-08-30 AU AU2022337199A patent/AU2022337199A1/en active Pending
- 2022-08-30 EP EP22865723.5A patent/EP4396225A4/en active Pending
- 2022-08-30 US US18/686,375 patent/US20250188194A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010162017A5 (enExample) | ||
| JP2010187677A5 (enExample) | ||
| CN112979802B (zh) | 抗人il-33单克隆抗体及其应用 | |
| JP2021036872A (ja) | 抗−ｔｎｆ抗体、組成物、方法および使用 | |
| JP6951256B2 (ja) | 抗体 | |
| JP2011514335A (ja) | Ｉｌ−１７ｒａ−ｉｌ−１７ｒｂアンタゴニストおよび該アンタゴニストの使用 | |
| JP2023080074A5 (enExample) | ||
| PT1419179E (pt) | Domínios de ligação de antigenes | |
| HRP20150937T1 (hr) | Pentaspecifiäśno protutijelo | |
| KR20140101727A (ko) | ＴＬ1ａ에 대한 항체 및 그의 용도 | |
| JP2009526084A5 (enExample) | ||
| US20150203840A1 (en) | Method for producing antibody molecules having inter-species, intra-target cross-reactivity | |
| JP2008509227A5 (enExample) | ||
| Zhang et al. | New insight into the pathogenesis of minimal change nephrotic syndrome: role of the persistence of respiratory tract virus in immune disorders | |
| Winters et al. | ANCA-positive glomerulonephritis and IgA nephropathy in a patient on propylthiouracil | |
| CN101541833A (zh) | Il-17受体a抗原结合蛋白质 | |
| JP2008502355A5 (enExample) | ||
| CN118047866A (zh) | 针对白介素6蛋白的单克隆抗体及其应用 | |
| JP2010524475A (ja) | オステオポンチンの機能エピトープ、それと特異的に結合するモノクローナル抗体及び用途 | |
| JP2007514414A (ja) | ｃ−Ｒｅｌ依存性サイトカイン産生を調節する組成物及び方法 | |
| US11965038B2 (en) | Pharmaceutical composition comprising antibody binding specifically to lysyl-tRNA synthetase N-terminus as effective ingredient for preventing or treating immune cell migration-related disease | |
| CN120518579A (zh) | 一种小分子抑制剂及其制备方法和应用 | |
| JP2022504403A (ja) | 心血管疾患の処置に有用な新規化合物 | |
| US20170044241A1 (en) | Single Chain Intrabodies that Alter Huntingtin Mutant Degradation | |
| CN101235086B (zh) | 重组人抗狂犬病毒抗体 |